Jim Simons Aurinia Pharmaceuticals Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AUPH
# of Institutions
195Shares Held
57.2MCall Options Held
469KPut Options Held
607K-
Armistice Capital, LLC New York, NY11.1MShares$93.3 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$77.7 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$33.3 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$24.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$23.3 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.19B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...